TP53 and neoplasm: Phenformin monotherapy, a mitochondrial complex I inhibitor, has been defined as a selective agent targeting lung tumors in KRASG12D/+/STK11-/- mice; no changes in tumor burden and survival have been observed in KRASG12D/+/p53-/- context [170].